A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma
- Resource Type
- Article
- Source
- In
Annals of Oncology September 2019 30(9):1514-1520 - Subject
- Language
- ISSN
- 0923-7534